Ocular Therapeutix (OCUL) Long-Term Debt Issuances (2013 - 2023)

Ocular Therapeutix's Long-Term Debt Issuances history runs 7 years deep, the most recent figure standing at -$80.5 million for Q4 2023.

• On a quarterly basis, Long-Term Debt Issuances changed N/A year-over-year to -$80.5 million in Q4 2023; TTM through Dec 2023 was -$78.4 million, a N/A change from a year earlier, with the FY2023 full-year figure at $2.0 million, changed N/A from the prior year.
• Long-Term Debt Issuances slipped to -$80.5 million in Q4 2023 per OCUL's latest filing, from $2.1 million in the prior quarter.
• Across five years, Long-Term Debt Issuances topped out at $37.3 million in Q1 2019 and bottomed at -$80.5 million in Q4 2023.
• The 3-year median for Long-Term Debt Issuances is $2.1 million (2021), against an average of -$7.8 million.
• Biggest YoY gain for Long-Term Debt Issuances was 3529.25% in 2019; the steepest drop was 104.54% in 2019.
• Year by year, Long-Term Debt Issuances stood at -$70000.0 in 2019, then jumped by 3077.14% to $2.1 million in 2021, then plunged by 3961.52% to -$80.5 million in 2023.
• Per Business Quant, the three latest OCUL Long-Term Debt Issuances figures stand at -$80.5 million (Q4 2023), $2.1 million (Q2 2021), and $2.1 million (Q1 2021).